{"DataElement":{"publicId":"6660900","version":"1","preferredName":"Cause of Death Reason CPTAC Name","preferredDefinition":"The circumstance or condition of greatest rank or importance that results in the death of a living being using the CPTAC permissible value set.","longName":"COD_RSN_CPTAC_NM","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"5915155","version":"1","preferredName":"Cause of Death Reason","preferredDefinition":"The circumstance or condition that results in the death of a living being._An explanation of the cause of some phenomenon or action.","longName":"DTH_RSN","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"4715451","version":"1","preferredName":"Cause of Death","preferredDefinition":"The circumstance or condition that results in the death of a living being.","longName":"C81239","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0ED41BF0-302F-7CC3-E050-BB89AD433DD7","latestVersionIndicator":"Yes","beginDate":"2015-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-02-11","modifiedBy":"ONEDATA","dateModified":"2015-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2390595","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE52ECB4-C378-617F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCISTD: NCI CRF Harmonization and Standards Initiative","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"55110257-BD72-7FAF-E053-F662850A3907","latestVersionIndicator":"Yes","beginDate":"2017-07-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-07-24","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"7/19/17 jk create for COD IC9/10 CDEs per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6660899","version":"1","preferredName":"CPTAC Cause of Death Name","preferredDefinition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics._The circumstance or condition that results in the death of a living being._The words or language units by which a thing is known.","longName":"CPTAC_COD_NM","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Viral Hepatitis","valueDescription":"Viral Hepatitis","ValueMeaning":{"publicId":"2946504","version":"1","preferredName":"Viral Hepatitis","longName":"2946504","preferredDefinition":"An acute or chronic inflammation of the liver parenchyma caused by viruses. Representative examples include hepatitis A, B, and C, cytomegalovirus hepatitis, and herpes simplex hepatitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral Hepatitis","conceptCode":"C35124","definition":"An acute or chronic inflammation of the liver parenchyma caused by viruses. Representative examples include hepatitis A, B, and C, cytomegalovirus hepatitis, and herpes simplex hepatitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74946BF8-78B6-20BB-E040-BB89AD436C7F","latestVersionIndicator":"Yes","beginDate":"2009-09-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-BFBC-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Terminal Sedation","valueDescription":"Terminal Sedation","ValueMeaning":{"publicId":"6660949","version":"1","preferredName":"Terminal Sedation","longName":"6660949","preferredDefinition":"The purposeful use of morphine, other opiates, or other pharmaceuticals at doses adequate to end life functions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Terminal Sedation","conceptCode":"C21115","definition":"The purposeful use of morphine, other opiates, or other pharmaceuticals at doses adequate to end life functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-BFCA-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-BFE3-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Symptoms, Signs and Abnormal Clinical and Laboratory Findings, NEC","valueDescription":"Symptoms, Signs and Abnormal Clinical and Laboratory Findings, NEC","ValueMeaning":{"publicId":"6660951","version":"1","preferredName":"Symptoms, Signs and Abnormal Clinical and Laboratory Findings, NEC","longName":"6660951v1.00","preferredDefinition":"A header term for symptoms, signs and abnormal clinical and laboratory findings that is not elsewhere classified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Symptoms, Signs and Abnormal Clinical and Laboratory Findings, NEC","conceptCode":"C157617","definition":"A header term for symptoms, signs and abnormal clinical and laboratory findings that is not elsewhere classified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-BFF0-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C009-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Suicide","valueDescription":"Suicide","ValueMeaning":{"publicId":"2572283","version":"1","preferredName":"Suicide","longName":"2572283","preferredDefinition":"The act of ending one's own life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suicide","conceptCode":"C3394","definition":"The act of ending one's own life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E768-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-01","modifiedBy":"COOPERM","dateModified":"2008-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C013-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Septicemia","valueDescription":"Septicemia","ValueMeaning":{"publicId":"4395780","version":"1","preferredName":"Septicemia","longName":"4395780","preferredDefinition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Septicemia","conceptCode":"C3364","definition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DA87-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C01D-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Respiratory System Disorder","valueDescription":"Respiratory System Disorder","ValueMeaning":{"publicId":"6660952","version":"1","preferredName":"Respiratory System Disorder","longName":"6660952","preferredDefinition":"Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Respiratory System Disorder","conceptCode":"C26871","definition":"A non-neoplastic or neoplastic disorder that affects the respiratory system. Representative examples include pneumonia, chronic obstructive pulmonary disease, pulmonary failure, lung adenoma, lung carcinoma, and tracheal carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C028-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C041-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Renal Hypertension","valueDescription":"Renal Hypertension","ValueMeaning":{"publicId":"6660954","version":"1","preferredName":"Renal Hypertension","longName":"6660954","preferredDefinition":"Hypertension caused by narrowing or occlusion of the renal arteries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Hypertension","conceptCode":"C3121","definition":"Hypertension caused by narrowing or occlusion of the renal arteries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C04E-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C067-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Pulmonary Emphysema","valueDescription":"Pulmonary Emphysema","ValueMeaning":{"publicId":"2558715","version":"1","preferredName":"Pulmonary Emphysema","longName":"2558715","preferredDefinition":"A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Emphysema","conceptCode":"C3348","definition":"A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B268-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C071-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Pregnancy Complication","valueDescription":"Pregnancy Complication","ValueMeaning":{"publicId":"6660955","version":"1","preferredName":"Pregnancy Complication","longName":"6660955","preferredDefinition":"The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or fetus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pregnancy Complication","conceptCode":"C34941","definition":"The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or fetus.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C07C-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C095-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Postpartum Complication","valueDescription":"Postpartum Complication","ValueMeaning":{"publicId":"6660957","version":"1","preferredName":"Postpartum Complication","longName":"6660957","preferredDefinition":"Any adverse event that arises in the six week period immediately following the delivery of a fetus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Postpartum Complication","conceptCode":"C116323","definition":"Any adverse event that arises in the six week period immediately following the delivery of a fetus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C0A2-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C0BB-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Pneumonia","valueDescription":"Pneumonia","ValueMeaning":{"publicId":"5296758","version":"1","preferredName":"Pneumonia","longName":"5296758","preferredDefinition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3565B23F-B158-8338-E050-BB89AD437D10","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C0C5-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Plasma Cell Myeloma","valueDescription":"Plasma Cell Myeloma","ValueMeaning":{"publicId":"5581351","version":"1","preferredName":"Plasma Cell Myeloma","longName":"5581351","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B9DD-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C0DA-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Perinatal Disorder","valueDescription":"Perinatal Disorder","ValueMeaning":{"publicId":"6660959","version":"1","preferredName":"Perinatal Disorder","longName":"6660959","preferredDefinition":"A non-neoplastic or neoplastic disorder occurring during the period from about five months before birth to one month after birth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perinatal Disorder","conceptCode":"C35095","definition":"A non-neoplastic or neoplastic disorder occurring during the period from about five months before birth to one month after birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C0E8-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C101-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Parkinson's Disease","valueDescription":"Parkinson's Disease","ValueMeaning":{"publicId":"3604284","version":"1","preferredName":"Parkinson's Disease","longName":"3604284","preferredDefinition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parkinson Disease","conceptCode":"C26845","definition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B91F-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C10B-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Other and Unspecified Infectious and Parasitic Diseases and their Sequelae","valueDescription":"Other and Unspecified Infectious and Parasitic Diseases and their Sequelae","ValueMeaning":{"publicId":"6660961","version":"1","preferredName":"Other and Unspecified Infectious and Parasitic Diseases and their Sequelae","longName":"6660961v1.00","preferredDefinition":"Unspecified infectious and parasitic diseases and their sequelae other than those otherwise specified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other and Unspecified Infectious and Parasitic Diseases and their Sequelae","conceptCode":"C157616","definition":"Unspecified infectious and parasitic diseases and their sequelae other than those otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C118-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C131-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Other and Unspecified Events of Undetermined Intent and their Sequelae","valueDescription":"Other and Unspecified Events of Undetermined Intent and their Sequelae","ValueMeaning":{"publicId":"6660963","version":"1","preferredName":"Other and Unspecified Events of Undetermined Intent and their Sequelae","longName":"6660963v1.00","preferredDefinition":"Events of undetermined intent and their sequelae other than those otherwise specified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other and Unspecified Events of Undetermined Intent and their Sequelae","conceptCode":"C157615","definition":"Events of undetermined intent and their sequelae other than those otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C13E-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C157-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Obesity","valueDescription":"Obesity","ValueMeaning":{"publicId":"2566203","version":"1","preferredName":"Obesity","longName":"2566203","preferredDefinition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obesity","conceptCode":"C3283","definition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFA8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-23","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-23","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C161-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Nutritional Disorder","valueDescription":"Nutritional Disorder","ValueMeaning":{"publicId":"6660965","version":"1","preferredName":"Nutritional Disorder","longName":"6660965","preferredDefinition":"Any condition related to a disturbance between proper intake and utilization of nourishment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nutritional Disorder","conceptCode":"C26836","definition":"Any condition related to a disturbance between proper intake and utilization of nourishment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C16F-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C188-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Non-Hodgkin Lymphoma","valueDescription":"Non-Hodgkin Lymphoma","ValueMeaning":{"publicId":"2573076","version":"1","preferredName":"Non-Hodgkin Lymphoma","longName":"2573076","preferredDefinition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Hodgkin Lymphoma","conceptCode":"C3211","definition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA81-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"KLINGERK","dateCreated":"2005-02-04","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C192-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Nephrotic Syndrome","valueDescription":"Nephrotic Syndrome","ValueMeaning":{"publicId":"3766434","version":"1","preferredName":"Nephrotic Syndrome","longName":"3766434","preferredDefinition":"Clinical association of heavy PROTEINURIA, HYPOALBUMINEMIA, and generalized EDEMA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nephrotic Syndrome","conceptCode":"C34845","definition":"A collection of symptoms that include severe edema, proteinuria, and hypoalbuminemia; it is indicative of renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCED4AE8-E22D-33A5-E040-BB89AD430FDC","latestVersionIndicator":"Yes","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C19D-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Nephritis","valueDescription":"Nephritis","ValueMeaning":{"publicId":"2581551","version":"1","preferredName":"Nephritis","longName":"2581551v1.00","preferredDefinition":"Inflammation of renal tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nephritis","conceptCode":"C26833","definition":"Inflammation of renal tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B9C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C1B2-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Neoplasm, Uncertain Whether Benign or Malignant","valueDescription":"Neoplasm, Uncertain Whether Benign or Malignant","ValueMeaning":{"publicId":"6660967","version":"1","preferredName":"Neoplasm, Uncertain Whether Benign or Malignant","longName":"6660967v1.00","preferredDefinition":"A neoplasm which, on morphologic grounds, can not be classified with certainty as benign or malignant.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm, Uncertain Whether Benign or Malignant","conceptCode":"C65157","definition":"A neoplasm which, on morphologic grounds, can not be classified with certainty as benign or malignant.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C1C0-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C1D9-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Malignant Neoplasm","valueDescription":"Malignant Neoplasm","ValueMeaning":{"publicId":"2749852","version":"1","preferredName":"Malignant Neoplasm","longName":"2749852","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D47F93B-9A03-2D84-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830EC13A-C1E3-147E-E053-F662850AE841","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Leukemia","valueDescription":"Leukemia","ValueMeaning":{"publicId":"3179697","version":"1","preferredName":"Leukemia","longName":"3179697","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F258D4-9F60-3E56-E040-BB89AD436715","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E7E00-1656-21DC-E053-F662850A1B80","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Kidney Disorder","valueDescription":"Renal Disorder","ValueMeaning":{"publicId":"2975595","version":"1","preferredName":"Renal Disorder","longName":"2975595","preferredDefinition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Disorder","conceptCode":"C3149","definition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0EDE-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E7E00-166A-21DC-E053-F662850A1B80","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Influenza","valueDescription":"Influenza","ValueMeaning":{"publicId":"3604288","version":"1","preferredName":"Influenza","longName":"3604288","preferredDefinition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza","conceptCode":"C53482","definition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B9AD-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E7E00-1674-21DC-E053-F662850A1B80","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Hypertension","valueDescription":"Hypertension","ValueMeaning":{"publicId":"2562555","version":"1","preferredName":"Hypertension","longName":"2562555","preferredDefinition":"Abnormally high blood pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C168-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E7E00-167E-21DC-E053-F662850A1B80","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Homicide by Assault","valueDescription":"Homicide by Assault","ValueMeaning":{"publicId":"6660947","version":"1","preferredName":"Homicide by Assault","longName":"6660947v1.00","preferredDefinition":"Death of an individual by physical violence from another.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Homicide by Assault","conceptCode":"C157608","definition":"Death of an individual by physical violence from another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E7E00-168C-21DC-E053-F662850A1B80","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E7E00-16A5-21DC-E053-F662850A1B80","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"HIV Infection","valueDescription":"HIV infection","ValueMeaning":{"publicId":"2579838","version":"1","preferredName":"HIV infection","longName":"2579838v1.00","preferredDefinition":"An infection caused by the human immunodeficiency virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HIV Infection","conceptCode":"C3108","definition":"An infection caused by the human immunodeficiency virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04EB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E7E00-16AF-21DC-E053-F662850A1B80","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Alzheimer's Disease","valueDescription":"Alzheimer's Disease","ValueMeaning":{"publicId":"3165575","version":"1","preferredName":"Alzheimer's Disease","longName":"3165575","preferredDefinition":"A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease","conceptCode":"C2866","definition":"A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C22C-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830B8ACA-B0C5-5D9D-E053-F662850A2B8C","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Arterial Disorder","valueDescription":"Arterial Disorder","ValueMeaning":{"publicId":"6660918","version":"1","preferredName":"Arterial Disorder","longName":"6660918","preferredDefinition":"An impairment of the structure or function of the blood vessels which carry blood away from the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arterial Disorder","conceptCode":"C35317","definition":"An impairment of the structure or function of the blood vessels which carry blood away from the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830B8ACA-B097-5D9D-E053-F662850A2B8C","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830B8ACA-B0B0-5D9D-E053-F662850A2B8C","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"4291759","version":"1","preferredName":"Anemia","longName":"4291759","preferredDefinition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6419-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830B8ACA-B0BA-5D9D-E053-F662850A2B8C","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Alcoholic Liver Disease","valueDescription":"Alcoholic Liver Disease","ValueMeaning":{"publicId":"3210771","version":"1","preferredName":"Alcoholic Liver Disease","longName":"3210771","preferredDefinition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcoholic Liver Disease","conceptCode":"C34783","definition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9D1A-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830B8ACA-B0CF-5D9D-E053-F662850A2B8C","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Accidental Injury","valueDescription":"Accidental Injury","ValueMeaning":{"publicId":"6660920","version":"1","preferredName":"Accidental Injury","longName":"6660920","preferredDefinition":"Unintentional trauma to the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accidental Injury","conceptCode":"C35165","definition":"Unintentional trauma to the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830B8ACA-B0DD-5D9D-E053-F662850A2B8C","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830B8ACA-B0F6-5D9D-E053-F662850A2B8C","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Abnormal Finding","valueDescription":"Abnormal Finding","ValueMeaning":{"publicId":"6660921","version":"1","preferredName":"Abnormal Finding","longName":"6660921","preferredDefinition":"A decision that an observation or result is outside the parameters considered normal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal Finding","conceptCode":"C82547","definition":"A decision that an observation or result is outside the parameters considered normal.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830B8ACA-B100-5D9D-E053-F662850A2B8C","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830B8ACA-B119-5D9D-E053-F662850A2B8C","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Hepatobiliary Disorder","valueDescription":"Liver and Biliary Tract Disorder","ValueMeaning":{"publicId":"2581086","version":"1","preferredName":"Liver and Biliary Tract Disorder","longName":"2581086","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatobiliary Disorder","conceptCode":"C3959","definition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09CB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-57E0-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Heart Disorder","valueDescription":"Heart Disorder","ValueMeaning":{"publicId":"3181118","version":"1","preferredName":"Heart Disorder","longName":"3181118","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Disorder","conceptCode":"C3079","definition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"991CC1A7-5429-0D9B-E040-BB89AD4320EF","latestVersionIndicator":"Yes","beginDate":"2011-01-05","endDate":null,"createdBy":"LUY","dateCreated":"2011-01-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-57F4-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Gallbladder Disorder","valueDescription":"Gallbladder Disorder","ValueMeaning":{"publicId":"6660933","version":"1","preferredName":"Gallbladder Disorder","longName":"6660933","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the gallbladder. Representative examples of non-neoplastic disorders include acute and chronic cholecystitis, often associated with the presence of gallstones. Representative examples of neoplastic disorders include adenoma, carcinoma, lymphoma, and sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Disorder","conceptCode":"C34631","definition":"A non-neoplastic or neoplastic disorder that affects the gallbladder. Representative examples of non-neoplastic disorders include acute and chronic cholecystitis, often associated with the presence of gallstones. Representative examples of neoplastic disorders include adenoma, carcinoma, lymphoma, and sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-57FE-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-5817-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Firearm Injury","valueDescription":"Firearm Injury","ValueMeaning":{"publicId":"6660935","version":"1","preferredName":"Firearm Injury","longName":"6660935v1.00","preferredDefinition":"An injury sustained by a gun.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Firearm Injury","conceptCode":"C157612","definition":"An injury sustained by a gun.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-5824-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-583D-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Finding During Childbirth Labor","valueDescription":"Finding During Childbirth Labor","ValueMeaning":{"publicId":"6660937","version":"1","preferredName":"Finding During Childbirth Labor","longName":"6660937","preferredDefinition":"Symptom, signs, test results in a pregnant mother childbirth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Finding During Childbirth Labor","conceptCode":"C92718","definition":"Symptom, signs, test results in a pregnant mother childbirth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-584A-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-5863-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Fall","valueDescription":"Fall","ValueMeaning":{"publicId":"2944776","version":"1","preferredName":"Fall","longName":"2944776","preferredDefinition":"A sudden movement downward, usually resulting in injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fall","conceptCode":"C50558","definition":"A sudden movement downward, usually resulting in injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7443E93B-ADB6-B364-E040-BB89AD434621","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"DWARZEL","dateModified":"2016-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-586D-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Essential Hypertension","valueDescription":"Essential Hypertension","ValueMeaning":{"publicId":"6660939","version":"1","preferredName":"Essential Hypertension","longName":"6660939","preferredDefinition":"Hypertension that presents without an identifiable cause.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Essential Hypertension","conceptCode":"C3478","definition":"Hypertension that presents without an identifiable cause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-587B-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-5894-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Dissecting Aortic Aneurysm","valueDescription":"Dissecting Aortic Aneurysm","ValueMeaning":{"publicId":"6660941","version":"1","preferredName":"Dissecting Aortic Aneurysm","longName":"6660941","preferredDefinition":"A dissecting aneurysm formed between the intimal and medial layers of the aortic wall due to a tear in the tunica intima.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dissecting Aortic Aneurysm","conceptCode":"C26751","definition":"A dissecting aneurysm formed between the intimal and medial layers of the aortic wall due to a tear in the tunica intima.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-58A1-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-58BA-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Diabetes Mellitus","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-58C4-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Death by Overdose","valueDescription":"Death by Overdose","ValueMeaning":{"publicId":"6660943","version":"1","preferredName":"Death by Overdose","longName":"6660943v1.00","preferredDefinition":"A death that is attributed to an excessive amount of a substance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Death by Overdose","conceptCode":"C157610","definition":"A death that is attributed to an excessive amount of a substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-58D1-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-58EA-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Death by Alcohol Ingestion","valueDescription":"Death by Alcohol Ingestion","ValueMeaning":{"publicId":"6660945","version":"1","preferredName":"Death by Alcohol Ingestion","longName":"6660945v1.00","preferredDefinition":"A death that is attributed to excessive alcohol ingestion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Death by Alcohol Ingestion","conceptCode":"C157611","definition":"A death that is attributed to excessive alcohol ingestion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E6E78-58F7-5FC2-E053-F662850A91D0","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-5910-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Cytogenetic Abnormality","valueDescription":"Cytogenetic Abnormality","ValueMeaning":{"publicId":"3210961","version":"1","preferredName":"Cytogenetic Abnormality","longName":"3210961","preferredDefinition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Abnormality","conceptCode":"C2950","definition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-BA5E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-591A-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Congenital Abnormality","valueDescription":"Congenital Abnormality","ValueMeaning":{"publicId":"2993000","version":"1","preferredName":"Congenital Abnormality","longName":"2993000","preferredDefinition":"Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Abnormality","conceptCode":"C2849","definition":"Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E1461A5-7AB2-590A-E040-BB89AD436E02","latestVersionIndicator":"Yes","beginDate":"2010-01-26","endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E6E78-5925-5FC2-E053-F662850A91D0","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BD-FFA3-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Complication due to Medical/Surgical Care","valueDescription":"Complication due to Medical/Surgical Care","ValueMeaning":{"publicId":"6660925","version":"1","preferredName":"Complication due to Medical/Surgical Care","longName":"6660925v1.00","preferredDefinition":"An untoward event that can be attributed to care received during a medical/surgical event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complication due to Medical/Surgical Care","conceptCode":"C157609","definition":"An untoward event that can be attributed to care received during a medical/surgical event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E36BD-FF5B-66AA-E053-F662850AC55B","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BD-FF74-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Clostridium Difficile Colitis","valueDescription":"Clostridium difficile Colitis","ValueMeaning":{"publicId":"6660926","version":"1","preferredName":"Clostridium difficile Colitis","longName":"6660926","preferredDefinition":"A bacterial infection of the colon secondary to infection with Clostridium difficile bacteria. This infection generally results from the loss of normal gut flora secondary to recent antibiotic use, and manifests as copious watery stools, with associated abdominal pain and myalgia. C. difficile is the most common cause of pseudomembranous colitis, and can progress to toxic megacolon if left untreated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clostridium difficile Colitis","conceptCode":"C35286","definition":"A bacterial infection of the colon secondary to infection with Clostridium difficile bacteria. This infection generally results from the loss of normal gut flora secondary to recent antibiotic use, and manifests as copious watery stools, with associated abdominal pain and myalgia. C. difficile is the most common cause of pseudomembranous colitis, and can progress to toxic megacolon if left untreated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E36BD-FF80-66AA-E053-F662850AC55B","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BD-FF99-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Chronic Lower Respiratory System Disorder","valueDescription":"Chronic Lower Respiratory System Disorder","ValueMeaning":{"publicId":"6660928","version":"1","preferredName":"Chronic Lower Respiratory System Disorder","longName":"6660928v1.00","preferredDefinition":"A non-neoplastic longstanding disorder of the lower respiratory system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Neoplastic Chronic Lower Respiratory System Disorder","conceptCode":"C157607","definition":"A non-neoplastic longstanding disorder of the lower respiratory system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E36BD-FFB1-66AA-E053-F662850AC55B","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BD-FFCA-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Chronic Liver Disease","valueDescription":"Chronic Liver Disease","ValueMeaning":{"publicId":"6660929","version":"1","preferredName":"Chronic Liver Disease","longName":"6660929","preferredDefinition":"Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Liver Disease","conceptCode":"C113609","definition":"Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E36BD-FFD4-66AA-E053-F662850AC55B","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BD-FFED-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Cholelithiasis","valueDescription":"Cholelithiasis","ValueMeaning":{"publicId":"6514326","version":"1","preferredName":"Cholelithiasis","longName":"6514326","preferredDefinition":"The presence of calculi in the gallbladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholelithiasis","conceptCode":"C122822","definition":"The presence of calculi in the gallbladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB15-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BD-FFF7-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Cerebrovascular Disorder","valueDescription":"Cerebrovascular Disorder","ValueMeaning":{"publicId":"2970710","version":"1","preferredName":"Cerebrovascular Disorder","longName":"2970710","preferredDefinition":"A broad category of disorders characterized by impairment of blood flow in the arteries and veins which supply the brain. These include CEREBRAL INFARCTION; BRAIN ISCHEMIA; HYPOXIA, BRAIN; INTRACRANIAL EMBOLISM AND THROMBOSIS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and VASCULITIS, CENTRAL NERVOUS SYSTEM. In common usage, the term cerebrovascular disorders is not limited to conditions that affect the cerebrum, but refers to vascular disorders of the entire brain including the DIENCEPHALON; BRAIN STEM; and CEREBELLUM.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebrovascular Disorder","conceptCode":"C2938","definition":"A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B03BA39-F9B5-A853-E040-BB89AD433913","latestVersionIndicator":"Yes","beginDate":"2009-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BE-000C-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Cardiovascular Disorder","valueDescription":"Cardiovascular Disorder","ValueMeaning":{"publicId":"2630208","version":"1","preferredName":"Cardiovascular Disorder","longName":"2630208","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels).  Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension.  Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular Disorder","conceptCode":"C2931","definition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8C3390-BBE2-1B34-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-20","modifiedBy":"COLBERTM","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BE-0016-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Carcinoma In Situ","valueDescription":"Carcinoma In Situ","ValueMeaning":{"publicId":"2935534","version":"1","preferredName":"Carcinoma In Situ","longName":"2935534v1.00","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4DE-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":"Updated definition with current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BE-0020-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Benign Neoplasm","valueDescription":"Benign Neoplasm","ValueMeaning":{"publicId":"2938141","version":"1","preferredName":"Benign Neoplasm","longName":"2938141v1.00","preferredDefinition":"A neoplasm characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Neoplasm","conceptCode":"C3677","definition":"A neoplasm characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7289D43E-7E19-ACC7-E040-BB89AD431D77","latestVersionIndicator":"Yes","beginDate":"2009-09-01","endDate":null,"createdBy":"UMLLOADER_TCGA","dateCreated":"2009-09-01","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BE-002A-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"B-Cell Neoplasm","valueDescription":"B-Cell Neoplasm","ValueMeaning":{"publicId":"6660930","version":"1","preferredName":"B-Cell Neoplasm","longName":"6660930","preferredDefinition":"A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow-growing) or aggressive (fast-growing). There are many different types of B-cell lymphomas, and prognosis and treatment depend on the type and stage of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Cell Neoplasm","conceptCode":"C27907","definition":"A lymphoproliferative disorder composed of neoplastic B-cells. It includes B-cell non-Hodgkin lymphomas, B-cell leukemias, plasma cell neoplasms, and B-cell proliferations of uncertain malignant potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E36BE-0037-66AA-E053-F662850AC55B","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BE-0050-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Automobile Accident","valueDescription":"Automobile Accident","ValueMeaning":{"publicId":"6660932","version":"1","preferredName":"Automobile Accident","longName":"6660932","preferredDefinition":"An accident occurring while aboard, or involving, an automobile.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Automobile Accident","conceptCode":"C34344","definition":"An accident occurring while aboard, or involving, an automobile.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830E36BE-005D-66AA-E053-F662850AC55B","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BE-0076-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"},{"value":"Atherosclerosis","valueDescription":"Atherosclerosis","ValueMeaning":{"publicId":"3210735","version":"1","preferredName":"Atherosclerosis","longName":"3210735","preferredDefinition":"Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atherosclerosis","conceptCode":"C35768","definition":"Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-96C6-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"830E36BE-0080-66AA-E053-F662850AC55B","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"ONEDATA","dateModified":"2019-03-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6660990","version":"1","preferredName":"Clinical Proteomic Tumor Analysis Consortium Cause of Death Name","preferredDefinition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.:The circumstance or condition that results in the death of a living being.:The words or language units by which a thing is known.","longName":"C157175:C81239:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Proteomic Tumor Analysis Consortium","conceptCode":"C157175","definition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83330F4C-D830-4439-E053-F662850A7B15","latestVersionIndicator":"Yes","beginDate":"2019-03-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-03-03","modifiedBy":"ONEDATA","dateModified":"2019-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8300B59A-9880-11B9-E053-F662850A31BA","latestVersionIndicator":"Yes","beginDate":"2019-02-28","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":"5/14/21 jk removed Phase PVs added in April, use VD 7658143 for Phase 3 questions.  4/24/21 jk added 4 PVs for Phase 3 FU form (HNSCC); Unknown for Phase 3 CRFs only.  2/12/20 ls CPTAC/Linda approved CDE; AI released, RS chg to Qualified.","administrativeNotes":"2023.9.5 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776734","version":"1","longName":"All Generic CRFs","context":"OCCPR"},{"publicId":"6601274","version":"1","longName":"Follow Up","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Cause of Death","type":"Preferred Question Text","description":"Cause of Death","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8300C4ED-1892-1F03-E053-F662850A34EE","latestVersionIndicator":"Yes","beginDate":"2019-02-28","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-28","modifiedBy":"KNABLEJ","dateModified":"2021-05-19","changeDescription":"5/19/21 Consider but detr new CDE (7658145) needed for Phase 3.  2/12/20 ls CPTAC/Linda approved CDE; AI released, RS chg to Qualified. 11/23/19 jk added F/U CSI.  3/1/19 created for use by CPTAC based on COD Standard CDEs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}